Human neuroblastomas with unfavorable biologies express high levels of brain-derived neurotrophic factor mRNA and a variety of its variants
- 5 February 2001
- journal article
- Published by Elsevier in Cancer Letters
- Vol. 164 (1) , 51-60
- https://doi.org/10.1016/s0304-3835(00)00715-1
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology
- Ministry of Health, Labour and Welfare
This publication has 20 references indexed in Scilit:
- Human and rat brain-derived neurotrophic factor and neurotrophin-3: Gene structures, distributions, and chromosomal localizationsPublished by Elsevier ,2004
- Cloning and chromosomal localization of the human TRK-B tyrosine kinase receptor gene (NTRK2)Genomics, 1995
- Functions of the neurotrophins during nervous system development: What the knockouts are teaching usCell, 1994
- Association between High Levels of Expression of the TRK Gene and Favorable Outcome in Human NeuroblastomaNew England Journal of Medicine, 1993
- Neurotrophin receptors: A window into neuronal differentiationNeuron, 1992
- Molecular Basis of Clinical Heterogeneity in NeuroblastomaJournal of Pediatric Hematology/Oncology, 1992
- Characterization of the 5′-flanking region of the human brain-derived neurotrophic factor geneBiochemical and Biophysical Research Communications, 1992
- Brain-derived neurotrophic factor prevents neuronal death in vivoNature, 1988
- Association of Multiple Copies of the N-mycOncogene with Rapid Progression of NeuroblastomasNew England Journal of Medicine, 1985
- Amplification of N- myc in Untreated Human Neuroblastomas Correlates with Advanced Disease StageScience, 1984